Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

$11.22 -0.22 (-1.92%)

High $11.49	Low $11.20	Trades 4,718	Turnover $7,499,551	Volume 664,557
30 June 2023 at 4:12pm

Market Cap (5-Oct) $5,151,129,600 (204th)	Close (30-Jun) $11.22 -0.22 (-1.92%)	Volume (30-Jun) 664,557	Shortsold (29-Sep) 36,267,030 (10.67%) (12th)
52w High $18.22	52w Low $8.26	P/E 140.85	EPS 0.14

[ARTICLE] M&A boom reshaping the ASX one deal at a time

MediaBot

January 26, 2022 12:24

A news article has been posted about Telix Pharmaceuticals on the AFR. The article was published around January 26, 2022 12:24, on 26 January 2022 at 12:24pm.

Deals targeting AusNet and Sydney Airport will free up two spots in the S&P/ASX 200, which are expected to be filled by Arena REIT and Telix Pharmaceuticals.

Read Article

TLX was $6.62 at the close of trade on 25 January 2022

Recent Articles about ASX:TLX
14-Sep	FDA Approves Telix's Brain Cancer Imaging Drug Pixclara - AFR company-announcements.afr.com
13-Sep	Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with ... company-announcements.afr.com
13-Sep	Telix Appoints David Gill as Chair - ASX Announcement - Market Index company-announcements.afr.com
21-Jul	Notice of change of interests of substantial holder - AFR company-announcements.afr.com
21-Jul	Q2 Business Update - Telix Pharmaceuticals Limited company-announcements.afr.com
19-Jul	Appendix 3H - Notification of cessation of securities - AFR company-announcements.afr.com
17-Jul	Appendix 3G - Notification of issue, conversion or payment up ... - AFR company-announcements.afr.com
4-Jul	Q1 2026 Strong Revenue Growth and Tx Pipeline Advancement company-announcements.afr.com
3-Jul	604 Page 1 of 6 - Market Index company-announcements.afr.com
3-Jul	Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain ... company-announcements.afr.com
Tracked

Find all articles about Telix Pharmaceuticals, including others on the AFR, on the media page.

You must login or register to post a comment.

You must be logged in to post a reply.

End of Day Prices

Date	Close	Volume	Change
02-Oct	$15.16	2,502,131	-0.45 (2.88%)
01-Oct	$15.61	1,618,652	-0.11 (0.70%)
30-Sep	$15.72	2,531,788	-0.43 (2.66%)
29-Sep	$16.15	1,975,751	+0.06 (0.37%)
28-Sep	$16.09	1,756,291	+0.19 (1.19%)
25-Sep	$15.90	1,553,094	+0.16 (1.02%)
24-Sep	$15.74	1,808,889	-0.34 (2.11%)
23-Sep	$16.08	3,343,138	-0.71 (4.23%)
22-Sep	$16.79	3,559,923	+1.03 (6.54%)
21-Sep	$15.76	4,324,837	-2.09 (11.71%)
18-Sep	$17.85	3,061,608	+0.40 (2.29%)
17-Sep	$17.45	2,265,947	+0.58 (3.44%)
16-Sep	$16.87	3,611,666	-0.88 (4.96%)
15-Sep	$17.75	6,075,869	+1.41 (8.63%)
14-Sep	$16.34	4,719,870	+0.67 (4.28%)
8 up, 7 down, and 0 flat days

Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

[ARTICLE] M&A boom reshaping the ASX one deal at a time

MediaBot

Followers

Prices

Announcements

End of Day Prices

Telix Pharmaceuticals Health Care Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

[ARTICLE] M&A boom reshaping the ASX one deal at a time

MediaBot

Followers

Prices

Announcements

End of Day Prices

Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom